Literature DB >> 17143969

Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study.

Tara Snelgrove1, Sooyeol Lim, Celia Greenwood, Lynette Peddle, Sean Hamilton, Robert Inman, Proton Rahman.   

Abstract

OBJECTIVE: Functional single nucleotide polymorphisms within the ectoplasmic domain of the Toll-like receptor 4 (TLR4) gene have been shown to result in an endotoxin-hyporesponsive phenotype and aberrant signal transduction for bacterial agonists. TLR4 is in proximity to a genome-wide linkage peak in 9q32-33. Given the proposed function and location of TLR4, we examined the association of 2 functional variants of TLR4 in patients with ankylosing spondylitis (AS) in Newfoundland.
METHODS: In total, 101 AS patients and 100 ethnically matched controls were genotyped, using the Sequenom MassArray platform, for 2 functional variants in the TLR4 gene: Asp299Gly (A/G polymorphism) and Thr399Ile (C/T polymorphism).
RESULTS: The minor allele frequency for the Asp299Gly variant (G) was significantly higher in AS cases compared to controls (7.5% vs 2.6%, respectively; OR 3.10, p = 0.037). The minor allele frequency for the Thr399Ile variant (T) for cases and controls was 7.4% vs 3.0% (OR 2.59, p = 0.071). Haplotype analysis using Haploview noted a higher proportion of GT in the cases (for GT, chi-squared p = 0.023).
CONCLUSION: Given the functional role of TLR4 variants in the innate immune system, larger studies are now warranted to elucidate the association of TLR4 variants in AS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143969

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Susceptibility to ankylosing spondylitis: evidence for the role of ERAP1, TGFb1 and TLR9 gene polymorphisms.

Authors:  Wenliang Wu; Yan Ding; Yunzhen Chen; Zhao Hua; Haichun Liu; Hongliang Wang; Guangjun Jiao
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 2.  Recent studies on the genetic basis of ankylosing spondylitis.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 3.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

4.  The potential importance of Toll-like receptors in ankylosing spondylitis.

Authors:  Filemon K Tan; Kiran Farheen
Journal:  Int J Clin Rheumtol       Date:  2011

5.  Single nucleotide polymorphism of toll-like receptor 4 (TLR4) is associated with juvenile spondyloarthritis in Croatian population.

Authors:  Marija Perica; Mandica Vidović; Lovro Lamot; Lana Tambić Bukovac; Sanja Kapitanović; Magdalena Perić; Jerko Barbić; Miroslav Harjaček
Journal:  Clin Rheumatol       Date:  2015-04-30       Impact factor: 2.980

6.  Lack of association of single nucleotide polymorphisms in toll-like receptors 2 and 4 with enthesitis-related arthritis category of juvenile idiopathic arthritis in Indian population.

Authors:  Arpita Myles; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

Review 7.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population.

Authors:  Kyoung-Sun Na; Tae-Hwan Kim; Proton Rahman; Lynette Peddle; Chan-Bum Choi; Robert D Inman
Journal:  Rheumatol Int       Date:  2007-11-22       Impact factor: 2.631

Review 9.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 10.  Toll-like receptors and NOD-like receptors in rheumatic diseases.

Authors:  William J McCormack; Andrew E Parker; Luke A O'Neill
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.